Literature DB >> 15996156

Pathological and clinical significance of increased intraepithelial lymphocytes (IELs) in small bowel mucosa.

Fuju Chang1, Ula Mahadeva, Harriet Deere.   

Abstract

Intestinal intraepithelial lymphocytes (IELs) belong to a unique T-cell population interspersed between epithelial cells of both the small and large intestine. It is becoming increasingly recognised that an increased number of IELs with a normal villous architecture is within the wide spectrum of histological abnormalities observed in coeliac disease. An increased number of IELs is the earliest pathological change following gluten challenge and a high IEL count may be the only sign of gluten sensitivity. Therefore, the finding of a raised IEL count with normal villous architecture is of sufficient clinical importance to be reported in routine small bowel biopsies. However, it is evident that not all small intestinal biopsy specimens showing increased IELs are explained by gluten sensitivity. Increased IELs in small bowel mucosa have also been associated with autoimmune disorders, tropical sprue, food protein intolerance, Helicobacter pylori-associated gastritis, peptic duodenitis, parasitic and viral infections, as well as the development of intestinal lymphoma. Histological examination of a biopsy specimen of the small bowel remains the diagnostic gold standard for coeliac disease. There will be an ever increasing demand for histological confirmation of gluten sensitivity in patients in whom the classic microscopic appearance of flattened villi may not have fully developed. The more widespread recognition by histopathologists of the pattern of injury manifested by increased numbers of IELs in intestinal biopsy specimens will certainly help in early diagnosis of coeliac disease, lessen diagnostic confusion and influence the modern practice of gastrointestinal tract medicine. This review discusses some of the recent developments in clinical pathology pertaining to increased IELs in small bowel mucosal biopsies.

Entities:  

Mesh:

Year:  2005        PMID: 15996156     DOI: 10.1111/j.1600-0463.2005.apm_204.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  16 in total

Review 1.  Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis.

Authors:  Anca I Catrina; Kevin D Deane; Jose U Scher
Journal:  Rheumatology (Oxford)       Date:  2014-12-23       Impact factor: 7.580

Review 2.  Coeliac disease and oats: a systematic review.

Authors:  N Y Haboubi; S Taylor; S Jones
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

Review 3.  The diagnosis and treatment of celiac disease.

Authors:  Detlef Schuppan; Klaus-Peter Zimmer
Journal:  Dtsch Arztebl Int       Date:  2013-12-06       Impact factor: 5.594

4.  A Prospective Study on the Usefulness of Duodenal Bulb Biopsies in Celiac Disease Diagnosis in Children: Urging Caution.

Authors:  Juha Taavela; Alina Popp; Ilma Rita Korponay-Szabo; Adina Ene; Martine Vornanen; Päivi Saavalainen; Marja-Leena Lähdeaho; Tarja Ruuska; Kaija Laurila; Alexandru Parvan; Ioana Anca; Kalle Kurppa; Markku Mäki
Journal:  Am J Gastroenterol       Date:  2016-01-05       Impact factor: 10.864

5.  Clinical utility of celiac disease-associated HLA testing.

Authors:  Kumar Pallav; Toufic Kabbani; Sohaib Tariq; Rohini Vanga; Ciaran P Kelly; Daniel A Leffler
Journal:  Dig Dis Sci       Date:  2014-04-06       Impact factor: 3.199

Review 6.  The Role of T-Cell Subsets in Chronic Inflammation in Celiac Disease and Inflammatory Bowel Disease Patients: More Common Mechanisms or More Differences?

Authors:  Tadakazu Hisamatsu; Ulrike Erben; Anja A Kühl
Journal:  Inflamm Intest Dis       Date:  2016-04-09

Review 7.  T-bet as a key regulator of mucosal immunity.

Authors:  Rami Mohamed; Graham M Lord
Journal:  Immunology       Date:  2016-02-23       Impact factor: 7.397

8.  Serologic celiac disease in patients with inflammatory bowel disease.

Authors:  Hamid Tavakkoli; Saeid Haghdani; Haiedeh Adilipour; Hamed Daghaghzadeh; Mohammad Minakari; Peyman Adibi; Khalil Ahmadi; Mohammah Hasan Emami
Journal:  J Res Med Sci       Date:  2012-02       Impact factor: 1.852

9.  Fenofibrate promotes PPARα-targeted recovery of the intestinal epithelial barrier at the host-microbe interface in dogs with diabetes mellitus.

Authors:  Katti R Crakes; Jully Pires; Nina Quach; Riley E Ellis-Reis; Rachel Greathouse; Kathyrnne A Chittum; Jörg M Steiner; Patricia Pesavento; Stanley L Marks; Satya Dandekar; Chen Gilor
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

Review 10.  The clinical response to gluten challenge: a review of the literature.

Authors:  Maaike J Bruins
Journal:  Nutrients       Date:  2013-11-19       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.